| Serial Number | 88314301 |
| Word Mark | PAPA & BARKLEY |
| Filing Date | Monday, February 25, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Friday, October 17, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 26, 2023 |
| Description of Mark | The mark consists of the stylized wording "PAPA & BARKLEY" in blue. In between the stacked words "PAPA" and "BARKLEY" is the ampersand sitting inside a blue outline of a circle with a narrow blue leaf running through the ampersand. The white in the drawing is for background areas only and is not a feature of the mark. |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| Pseudo Mark | PAPA AND BARKLEY |
| Goods and Services | Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional supplements in drop form, capsule form, and liquid form, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabichromene solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabielsoin solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinol solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabinodiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabidiol solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabicitran solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Orally-ingestible nutritional and dietary supplements in the form of capsules, pills, liquids, tablets, powders, extracts, and tinctures, for use in acting upon or caring for stress, loss of appetite, anxiety, fatigue, wellbeing, and mood enhancement, all the foregoing containing cannabimovone solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and none of foregoing featuring more than trace amounts of cannabidiol; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids |
| Goods and Services | Essential oils for cosmetic purposes, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Essential oils for cosmetic purposes, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body oils in drop form, capsule form, and liquid form, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Cosmetics, namely, non-medicated body ointments in drop form and liquid form, all the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated body soaks, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nonmedicated body soaks, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabis ingredients solely derived from Cannabis sativa L. with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Electronic cigarette liquid (e-liquid) comprised of essential oils, all the foregoing containing cannabinoids solely derived from Cannabis sativa L. with a delta9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis |
| International Class | 003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices. |
| US Class Codes | 001, 004, 006, 050, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 15, 2019 |
| Primary Code | 003 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 15, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MAMMOTH MANAGEMENT, INC. |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | NORTH HOLLYWOOD, CA 91605 |
| Party Name | Egg Rock Holdings, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Glendale, CA 91206 |
| Party Name | Egg Rock Holdings, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Glendale, CA 91206 |
| Event Date | Event Description |
| Thursday, February 28, 2019 | NEW APPLICATION ENTERED |
| Friday, March 15, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 21, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, May 6, 2019 | ASSIGNED TO EXAMINER |
| Monday, May 6, 2019 | ASSIGNED TO EXAMINER |
| Monday, October 28, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, October 29, 2019 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 29, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 29, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 29, 2020 | TEAS REQUEST TO DIVIDE RECEIVED |
| Wednesday, April 29, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 4, 2020 | ASSIGNED TO LIE |
| Wednesday, April 29, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 11, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, May 11, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, April 29, 2020 | DIVISIONAL REQUEST RECEIVED |
| Monday, May 11, 2020 | DIVISIONAL PROCESSING COMPLETE |
| Saturday, June 13, 2020 | FINAL REFUSAL WRITTEN |
| Saturday, June 13, 2020 | FINAL REFUSAL E-MAILED |
| Saturday, June 13, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Sunday, December 13, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, December 14, 2020 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, December 14, 2020 | EXPARTE APPEAL RECEIVED AT TTAB |
| Monday, December 14, 2020 | EX PARTE APPEAL-INSTITUTED |
| Monday, December 14, 2020 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, December 14, 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Monday, December 14, 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Monday, December 14, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 15, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 15, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 15, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 14, 2020 | DIVISIONAL REQUEST RECEIVED |
| Wednesday, December 23, 2020 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, December 23, 2020 | DIVISIONAL PROCESSING COMPLETE |
| Monday, April 26, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, April 26, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, April 26, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 22, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 22, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, October 23, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 14, 2022 | SUBSEQUENT FINAL REFUSAL WRITTEN |
| Thursday, April 14, 2022 | SUBSEQUENT FINAL EMAILED |
| Thursday, April 14, 2022 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
| Sunday, July 10, 2022 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Friday, October 14, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, October 20, 2022 | ASSIGNED TO LIE |
| Thursday, October 20, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 20, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, February 25, 2023 | ACTION CONTINUING FINAL - COMPLETED |
| Saturday, February 25, 2023 | ACTION DENYING REQ FOR RECON E-MAILED |
| Saturday, February 25, 2023 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |
| Friday, May 5, 2023 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Tuesday, November 21, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, November 21, 2023 | EXPARTE APPEAL TERMINATED |
| Wednesday, December 6, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 26, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 26, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 20, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, July 8, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 8, 2024 | SOU EXTENSION 1 FILED |
| Monday, July 8, 2024 | SOU EXTENSION 1 GRANTED |
| Monday, July 8, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 29, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, September 13, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, September 13, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, September 13, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, September 13, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, September 13, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, September 13, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Wednesday, February 5, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 5, 2025 | SOU EXTENSION 2 FILED |
| Monday, July 7, 2025 | SOU EXTENSION 2 GRANTED |
| Monday, July 7, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, October 17, 2025 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, October 17, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, November 24, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, November 24, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, November 24, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, November 24, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, November 24, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |